Trial intelligence / Profile preview

Oral paracetamol for anxiety, distress, and pain during port needle insertion in children with cancer

2005-002110-38Phase 3Completed

Sponsor
Department of Pediatric Hematology
Start
May 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in cancer comparing Alvedon + EMLA with Placebo + EMLA (2 arms). Primary endpoint: Pain during port needle insertion. Started May 2005; status: completed.

02

Drugs

acetaminophen
03

Conditions

cancer

Beyond the preview

Go deeper on 2005-002110-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002110-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call